fda drug shortages semaglutide injection status resolved 2025 As of February 21, 2025, the updated its shortage list, marking the shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Hims & Hers Health stock

This dual effect lowers blood glucose levels, making semaglutide effective in type 2 diabetes management

If insurance doesnt cover your prescription, the average cost of brand-name tirzepatide (Mounjaro and Zepbound) is around $1,000 to $1,200 per month, while the average cost of brand-name semaglutide (Wegovy and Ozempic) is around $900 to $1,700 per month

The HD dose is for under-responders, not first-line use

FDA encourages health care providers and compounders to provide patients with the appropriate syringe size for the intended dose and counsel patients on how to measure the intended dose using the syringe, the agency said